Revolution Capital Lease Obligations vs Retained Earnings Analysis

RVMDW Stock   0.09  0  4.88%   
Revolution Medicines, financial indicator trend analysis is much more than just breaking down Revolution Medicines, prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Revolution Medicines, is a good investment. Please check the relationship between Revolution Medicines, Capital Lease Obligations and its Retained Earnings accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revolution Medicines, Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Capital Lease Obligations vs Retained Earnings

Capital Lease Obligations vs Retained Earnings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Revolution Medicines, Capital Lease Obligations account and Retained Earnings. At this time, the significance of the direction appears to have pay attention.
The correlation between Revolution Medicines,'s Capital Lease Obligations and Retained Earnings is -0.91. Overlapping area represents the amount of variation of Capital Lease Obligations that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Revolution Medicines, Warrant, assuming nothing else is changed. The correlation between historical values of Revolution Medicines,'s Capital Lease Obligations and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Lease Obligations of Revolution Medicines, Warrant are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Capital Lease Obligations i.e., Revolution Medicines,'s Capital Lease Obligations and Retained Earnings go up and down completely randomly.

Correlation Coefficient

-0.91
Relationship DirectionNegative 
Relationship StrengthSignificant

Capital Lease Obligations

Revolution Medicines, capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Revolution Medicines, asset purchases. For example, Revolution Medicines, can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Revolution Medicines, control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.
Most indicators from Revolution Medicines,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Revolution Medicines, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revolution Medicines, Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
At this time, Revolution Medicines,'s Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value is likely to climb to about 7.3 B in 2025, whereas Tax Provision is likely to drop (790.6 K) in 2025.
 2022 2023 2024 2025 (projected)
Interest Income9.2M47.5M86.9M91.2M
Net Interest Income9.2M47.2M86.9M91.2M

Revolution Medicines, fundamental ratios Correlations

1.00.861.00.9-0.990.880.880.910.46-0.98-0.80.911.00.830.890.990.930.990.91.0-0.770.451.0-0.880.92
1.00.851.00.9-0.990.880.880.910.46-0.98-0.810.911.00.830.890.990.920.990.91.0-0.770.451.0-0.880.92
0.860.850.860.82-0.850.970.940.810.52-0.84-0.50.920.830.660.810.850.920.840.830.86-0.560.550.86-0.550.87
1.01.00.860.9-0.990.880.890.910.46-0.98-0.80.911.00.830.890.990.930.990.91.0-0.770.461.0-0.880.92
0.90.90.820.9-0.910.870.891.00.15-0.94-0.540.950.890.951.00.870.970.931.00.89-0.880.310.9-0.680.97
-0.99-0.99-0.85-0.99-0.91-0.86-0.86-0.92-0.440.980.81-0.93-0.99-0.84-0.91-0.99-0.93-0.98-0.92-0.990.76-0.35-0.990.87-0.95
0.880.880.970.880.87-0.860.990.860.44-0.89-0.460.910.840.750.860.850.950.880.880.89-0.660.660.88-0.590.89
0.880.880.940.890.89-0.860.990.880.37-0.9-0.440.90.840.780.880.840.950.890.890.89-0.730.670.89-0.60.88
0.910.910.810.911.0-0.920.860.880.18-0.95-0.580.950.90.971.00.880.970.931.00.91-0.880.310.91-0.70.98
0.460.460.520.460.15-0.440.440.370.18-0.31-0.550.370.470.090.140.50.350.360.150.470.20.50.46-0.380.35
-0.98-0.98-0.84-0.98-0.940.98-0.89-0.9-0.95-0.310.73-0.92-0.98-0.87-0.94-0.97-0.94-1.0-0.95-0.980.86-0.41-0.980.86-0.93
-0.8-0.81-0.5-0.8-0.540.81-0.46-0.44-0.58-0.550.73-0.61-0.84-0.52-0.55-0.85-0.56-0.77-0.54-0.80.46-0.11-0.80.93-0.63
0.910.910.920.910.95-0.930.910.90.950.37-0.92-0.610.910.870.950.910.980.910.960.91-0.740.330.91-0.650.98
1.01.00.831.00.89-0.990.840.840.90.47-0.98-0.840.910.830.891.00.910.990.891.0-0.760.391.0-0.90.92
0.830.830.660.830.95-0.840.750.780.970.09-0.87-0.520.870.830.960.790.90.860.950.82-0.870.270.83-0.650.92
0.890.890.810.891.0-0.910.860.881.00.14-0.94-0.550.950.890.960.870.970.921.00.89-0.890.290.89-0.670.97
0.990.990.850.990.87-0.990.850.840.880.5-0.97-0.850.911.00.790.870.90.980.870.99-0.730.390.99-0.90.91
0.930.920.920.930.97-0.930.950.950.970.35-0.94-0.560.980.910.90.970.90.930.970.92-0.780.450.93-0.650.98
0.990.990.840.990.93-0.980.880.890.930.36-1.0-0.770.910.990.860.920.980.930.930.99-0.830.430.99-0.880.92
0.90.90.830.91.0-0.920.880.891.00.15-0.95-0.540.960.890.951.00.870.970.930.9-0.880.310.9-0.680.97
1.01.00.861.00.89-0.990.890.890.910.47-0.98-0.80.911.00.820.890.990.920.990.9-0.760.461.0-0.880.92
-0.77-0.77-0.56-0.77-0.880.76-0.66-0.73-0.880.20.860.46-0.74-0.76-0.87-0.89-0.73-0.78-0.83-0.88-0.76-0.21-0.770.67-0.76
0.450.450.550.460.31-0.350.660.670.310.5-0.41-0.110.330.390.270.290.390.450.430.310.46-0.210.46-0.260.31
1.01.00.861.00.9-0.990.880.890.910.46-0.98-0.80.911.00.830.890.990.930.990.91.0-0.770.46-0.880.92
-0.88-0.88-0.55-0.88-0.680.87-0.59-0.6-0.7-0.380.860.93-0.65-0.9-0.65-0.67-0.9-0.65-0.88-0.68-0.880.67-0.26-0.88-0.69
0.920.920.870.920.97-0.950.890.880.980.35-0.93-0.630.980.920.920.970.910.980.920.970.92-0.760.310.92-0.69
Click cells to compare fundamentals

Revolution Medicines, Account Relationship Matchups

Revolution Medicines, fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets567.4M738.0M811.9M2.1B2.6B2.7B
Other Current Liab18.8M21.5M22.7M74.7M96.6M101.4M
Total Current Liabilities47.2M18.9M62.0M143.9M163.9M87.8M
Total Stockholder Equity474.7M602.6M685.2M1.8B2.3B2.4B
Property Plant And Equipment Net36.3M71.2M73.7M100.0M141.8M78.9M
Retained Earnings(265.5M)(452.6M)(701.3M)(1.1B)(1.7B)(1.7B)
Accounts Payable12.6M14.1M21.3M61.8M54.4M32.2M
Cash104.3M108.5M161.4M696.1M543.1M298.8M
Non Current Assets Total113.3M160.9M151.7M182.4M230.7M169.7M
Non Currrent Assets Other(19.1M)(14.5M)(23.4M)10.1M17.6M18.4M
Common Stock Shares Outstanding66.6M72.8M80.6M113.1M167.7M101.5M
Short Term Investments336.5M468.6M483.5M1.2B1.7B1.8B
Non Current Liabilities Total45.5M116.5M64.8M91.7M129.2M86.6M
Capital Lease Obligations32.7M66.6M64.2M87.9M135.8M71.0M
Other Current Assets7.0M6.8M10.6M25.1M38.3M40.2M
Total Liab92.7M135.4M126.7M235.5M293.1M174.4M
Net Invested Capital474.7M602.6M685.2M1.8B2.3B2.4B
Property Plant And Equipment Gross44.4M82.0M88.2M117.7M163.6M93.3M
Total Current Assets454.1M577.1M660.2M1.9B2.3B2.4B
Capital Stock7K8K9K16K18K17.1K
Non Current Liabilities Other632K634K301K1.5M670K797.5K
Net Working Capital406.9M529.4M598.2M1.7B2.2B2.3B
Intangible Assets60.9M59.9M58.8M57.7M56.7M47.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revolution Stock Analysis

When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.